Segantii Capital Management’s Immunomedics Inc IMMU Stock Holding History

Segantii Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-854,406	Closed	-$72.7M	–	138
2020 Q3	$72.7M	Buy	+854,406	New	+$43.2M	5.61%	3
2017 Q2	–	Sell	-3,400	Closed	-$22K	–	333
2017 Q1	$22K	Buy	+3,400	New	+$17.2K	﹤0.01%	357

Segantii Capital Management's IMMU Position: Q4 2020 in Review

Segantii Capital Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 854,406 shares — an estimated $72.7M sold.

Segantii Capital Management first reported a position in IMMU in Q1 2017 and held it in 2 quarters. The position peaked at $72.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Segantii Capital Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Segantii Capital Management sold 854,406 Immunomedics Inc shares in Q4 2020, an estimated $72.7M.
Segantii Capital Management first reported a position in Immunomedics Inc in Q1 2017 and held it in 2 quarters.
Segantii Capital Management's Immunomedics Inc position peaked at $72.7M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Segantii Capital Management's 13F filing for Q4 2020, filed 27 Jan 2021.